| Title |
Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, August 2020
|
| DOI | 10.2147/tcrm.s223468 |
| Pubmed ID | |
| Authors |
Stephanie Si, David T Teachey |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 22% |
| Argentina | 1 | 11% |
| Colombia | 1 | 11% |
| Saudi Arabia | 1 | 11% |
| Unknown | 4 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 78% |
| Practitioners (doctors, other healthcare professionals) | 1 | 11% |
| Scientists | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 163 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 19 | 12% |
| Researcher | 15 | 9% |
| Other | 13 | 8% |
| Student > Master | 12 | 7% |
| Student > Ph. D. Student | 11 | 7% |
| Other | 28 | 17% |
| Unknown | 65 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 47 | 29% |
| Biochemistry, Genetics and Molecular Biology | 14 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 6% |
| Nursing and Health Professions | 6 | 4% |
| Agricultural and Biological Sciences | 4 | 2% |
| Other | 15 | 9% |
| Unknown | 67 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2022.
All research outputs
#7,444,683
of 25,837,817 outputs
Outputs from Therapeutics and Clinical Risk Management
#379
of 1,325 outputs
Outputs of similar age
#156,129
of 429,134 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#7
of 12 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,325 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,134 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.